Center for Influenza Virus Research
Shigeyuki Itamura has not added Biography.
If you are Shigeyuki Itamura and would like to personalize this page please email our Author Liaison for assistance.
Avirulent Avian influenza virus as a vaccine strain against a potential human pandemic.
Journal of virology Oct, 1999 | Pubmed ID: 10482580
Intranasal inoculation of a recombinant influenza virus containing exogenous nucleotides in the NS segment induces mucosal immune response against the exogenous gene product in mice.
Vaccine Feb, 2002 | Pubmed ID: 11858865
[SARS, pandemic influenza, avian influenza: quest for missing link].
Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme May, 2004 | Pubmed ID: 15160886
A subcutaneously injected UV-inactivated SARS coronavirus vaccine elicits systemic humoral immunity in mice.
International immunology Oct, 2004 | Pubmed ID: 15314040
Productive infection in the murine central nervous system with avian influenza virus A (H5N1) after intranasal inoculation.
Acta neuropathologica Dec, 2004 | Pubmed ID: 15480712
Immunological detection of severe acute respiratory syndrome coronavirus by monoclonal antibodies.
Japanese journal of infectious diseases Apr, 2005 | Pubmed ID: 15858286
Vesicular stomatitis virus pseudotyped with severe acute respiratory syndrome coronavirus spike protein.
The Journal of general virology Aug, 2005 | Pubmed ID: 16033974
Intranasal administration of adjuvant-combined recombinant influenza virus HA vaccine protects mice from the lethal H5N1 virus infection.
Microbes and infection Oct, 2006 | Pubmed ID: 16968669
Pathological and virological analyses of severe acute respiratory syndrome-associated coronavirus infections in experimental animals.
Advances in experimental medicine and biology , 2006 | Pubmed ID: 17037588
Intranasal immunization with H5N1 vaccine plus Poly I:Poly C12U, a Toll-like receptor agonist, protects mice against homologous and heterologous virus challenge.
Microbes and infection Sep, 2007 | Pubmed ID: 17890128
Cross-protection against H5N1 influenza virus infection is afforded by intranasal inoculation with seasonal trivalent inactivated influenza vaccine.
The Journal of infectious diseases Nov, 2007 | Pubmed ID: 17922395
Pathology and virus dispersion in cynomolgus monkeys experimentally infected with severe acute respiratory syndrome coronavirus via different inoculation routes.
International journal of experimental pathology Dec, 2007 | Pubmed ID: 18039277
Human H5N2 avian influenza infection in Japan and the factors associated with high H5N2-neutralizing antibody titer.
Journal of epidemiology , 2008 | Pubmed ID: 18603824
[Trends and perspectives in development of influenza vaccines].
Nihon rinsho. Japanese journal of clinical medicine Sep, 2010 | Pubmed ID: 20845750
[The latest trend and prospects of development of influenza vaccine].
Nihon rinsho. Japanese journal of clinical medicine Sep, 2011 | Pubmed ID: 21922754
Newly established monoclonal antibodies for immunological detection of H5N1 influenza virus.
Japanese journal of infectious diseases , 2012 | Pubmed ID: 22274153
Influenza A whole virion vaccine induces a rapid reduction of peripheral blood leukocytes via interferon-α-dependent apoptosis.
Vaccine Apr, 2013 | Pubmed ID: 23434386
WHO recommendations for the viruses used in the 2013-2014 Northern Hemisphere influenza vaccine: Epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from October 2012 to January 2013.
Vaccine Aug, 2014 | Pubmed ID: 24582632
Broad cross-reactive epitopes of the H5N1 influenza virus identified by murine antibodies against the A/Vietnam/1194/2004 hemagglutinin.
PloS one , 2014 | Pubmed ID: 24945805
Development of a sensitive novel diagnostic kit for the highly pathogenic avian influenza A (H5N1) virus.
BMC infectious diseases Jul, 2014 | Pubmed ID: 24992826
Deciphering antigen-responding antibody repertoires by using next-generation sequencing and confirming them through antibody-gene synthesis.
Biochemical and biophysical research communications 05, 2017 | Pubmed ID: 28412367
Distorted antibody repertoire developed in the absence of pre-B cell receptor formation.
Biochemical and biophysical research communications 01, 2018 | Pubmed ID: 29191653
Efficient protection of mice from influenza A/H1N1pdm09 virus challenge infection via high avidity serum antibodies induced by booster immunizations with inactivated whole virus vaccine.
Heliyon Jan, 2019 | Pubmed ID: 30623129
Lin Sun1,
Naoko Kono2,
Hiroyuki Toh3,
Hanbing Xue1,
Kaori Sano4,5,
Tadaki Suzuki4,
Akira Ainai4,
Yasuko Orba6,
Junya Yamagishi7,8,
Hideki Hasegawa4,5,
Yoshimasa Takahashi9,
Shigeyuki Itamura2,
Kazuo Ohnishi9,10
1Graduate School of Life and Environmental Sciences, University of Tsukuba,
2Center for Influenza Virus Research, National Institute of Infectious Diseases,
3School of Science and Technology, Kwansei Gakuin University,
4Department of Pathology, National Institute of Infectious Diseases,
5Division of Infectious Diseases Pathology, Department of Global Infectious Diseases, Tohoku University Graduate School of Medicine,
6Division of Molecular Pathobiology, Research Center for Zoonosis Control, Hokkaido University,
7Division of Collaboration and Education, Research Center for Zoonosis Control, Hokkaido University,
8Global Station for Zoonosis Control, GI-CoRE, Hokkaido University,
9Department of Immunology, National Institute of Infectious Diseases,
10Faculty of Life and Environmental Sciences, University of Tsukuba
ÜBER JoVE
Copyright © 2024 MyJoVE Corporation. Alle Rechte vorbehalten